ArticleActa oncologica (Stockholm, Sweden)2019

Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: a Danish population-based nested case-control study.

Cathrine F Hjorth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.